{
  "page_summary": "This page provides descriptions of common breast cancer measurements, including receptor status (intensity score, total score), HER2 status, Ki-67 labeling index, tumor size, tumor bed size, surgical margin status, cellularity, percentage of in situ carcinoma, and size of the largest lymph node. The discussion focuses on the clinical meaning and role of these measurements in informing prognosis and treatment decisions but does not formally define clinical trial endpoints.",
  "endpoint_candidates": []
}